Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| British Columbia Cancer Agency | OTHER |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The purpose of this study is to test the feasibility of the study protocol. The study protocol was designed to evaluate questions - "Do educational materials improve dual x-ray absorptiometry (DXA) screening rates for women diagnosed with breast cancer" and "Does educational materials delivered by the participant's selected choice change DXA screening rates compared to the conventional mail method?".
"Bone health management" for osteoporosis is important for women diagnosed with breast cancer. Osteoporosis can lead to bones breaking easily. Broken bones may make living independently challenging. Effective bone health management can reduce the risk of broken bones. This study will examine whether providing "osteoporosis information" to women diagnosed with breast cancer will promote their bone health management. With the current advance in technology, people are more interested in receiving information by email or smartphone text messaging. This study will also examine whether delivering osteoporosis information in different ways will change bone health management.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Educational materials/mail | Experimental | Participants in this group will receive educational materials by mail on the first day of the follow-up period. |
|
| Educational materials/participant choice | Experimental | Participants in this group will receive educational materials by participant choice on the first day of the follow-up period. |
|
| Control | No Intervention | Participants in this group will not receive any educational materials during hte follow-up period. Educational materials will be sent by mail after the completion of this study. |
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Educational materials/mail | Behavioral | Participants in this group will receive any educational materials by mail during hte follow-up period. |
|
| Measure | Description | Time Frame |
|---|---|---|
| DXA screening rates | 6 months |
| Measure | Description | Time Frame |
|---|---|---|
| Percentage of participants diagnosed with osteoporosis | 6 months | |
| Percentage of participants initiating osteoporosis medication | 6 months | |
| Changes in Calcium in take |
Not provided
Inclusion Criteria:
Exclusion criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Martin Dawes, MD, PhD | University of British Columbia | Principal Investigator |
| John J. Spinelli, PhD | British Columbia Cancer Agency | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| BC Cancer Research Centre | Vancouver | British Columbia | V5Z 1L3 | Canada |
Not provided
Not provided
Not provided
Not provided
Not provided
| Type | Date | Date Unknown |
|---|---|---|
| Release | Apr 6, 2018 | |
| Reset | Oct 18, 2018 | |
| Release | Oct 19, 2018 | |
| Reset | Dec 4, 2018 | |
| Release | Jul 6, 2019 | |
| Reset | Aug 14, 2019 |
Not provided
Not provided
| Release Date | Unrelease Date | Unrelease Date Unknown | Reset Date | MCP Release Number |
|---|---|---|---|---|
| Apr 6, 2018 | Oct 18, 2018 | |||
| Oct 19, 2018 |
| ID | Term |
|---|---|
| D010024 | Osteoporosis |
| D001943 | Breast Neoplasms |
| ID | Term |
|---|---|
| D001851 | Bone Diseases, Metabolic |
| D001847 | Bone Diseases |
| D009140 | Musculoskeletal Diseases |
| D008659 | Metabolic Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
data analyst
| Educational materials/participant choice | Behavioral | Participants in this group will not receive any educational materials by participant choice during hte follow-up period. |
|
measured as mg per week using validated questionnaires |
| 6 months |
| Changes in vitamin D status | measured as scores using validated questionnaires | 6 months |
| Changes in exercise patterns | measured as scores using validated questionnaires | 6 months |
| Dec 4, 2018 |
| Jul 6, 2019 | Aug 14, 2019 |
| D009750 |
| Nutritional and Metabolic Diseases |
| D009371 | Neoplasms by Site |
| D009369 | Neoplasms |
| D001941 | Breast Diseases |
| D012871 | Skin Diseases |
| D017437 | Skin and Connective Tissue Diseases |